News/Events

EchoLaser is now NMPA approved

Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by Esaote). NMPA approval confirms once again the robustness of clinical data in urology, where EchoLaser has been demonstrated to be a safe and efficacious alternative to surgery for the treatment of Benign Prostatic Hyperplasia (BPH) and some forms of prostatic cancer.

New office dedicated to the EchoLaser in Cisanello, Pisa

🚀 Exciting News in Medical Innovation! 🚀
We are thrilled to share that the Azienda Ospedaliero-Universitaria Pisana Ospedale Cisanello has recently introduced groundbreaking minimally invasive procedures for thyroid and prostate treatments, utilizing EchoLaser TPLA soractelite and ModìLite. To further support this initiative, it has opened a dedicated office specifically for these laser treatments. These innovative techniques offer patients safer, faster, and more effective options with minimal recovery time. This marks a significant advancement in patient care, aligning with our commitment to improving health outcomes through cutting-edge technology.
Read more about this breakthrough here: https://www.lanazione.it/…/pisa-nuove-procedure…
We would like to share a special thanks to our user who made this possible:
Prof. Riccardo Bartoletti, Prof. Gabriele Materazzi with his equipe Dr. Piermarco Papini and Dr. Enrico Ambrosini, Dr.ssa Teresa Rago and Dr. Rocco Rago.

EchoLaser for Thyroid

The advantages of EchoLaser for the thermoablation of thyroid nodules are clear and obvious.
This explains DR. Fedele Antonio De Marino, Expert in the field.

Contact us to learn more : info@elesta-echolaser.com

https://napoli.repubblica.it/dossier-adv/eccellenze-della-campania/2024/05/21/news/noduli_alla_tiroide_ecco_come_affrontarli-423114593/

EchoLaser on Corriere della Sera

Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership.

Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite.

It is a novel technique which is gaining fast adoption internationally. Safety and efficacy profile was confirmed by many publications, which include two RCT’s vs TURP and one systematic review. Despite new, durability data on this treatment modality at 2 and 3 years are also published (5 years data coming soon).

Link to the article: https://www.corriere.it/salute/sportello_cancro/24_aprile_01/ipertrofia-della-prostata-quando-operare-e-quali-sono-le-tecniche-piu-indicate-a-seconda-anche-dell-eta-29c017e9-d1a3-49a7-abf7-cfe11e525xlk.shtml

<a id="form"></a>

 

Promotional Material

Fill in the following form to receive commercial and / or promotional communications

 

    I give my consent for the Treatment of my personal data

    I give my consent to receive information about products, events and news

    Please make your choiche

    Please select your country/geographic area

    The USA version of Elesta website is not yet available. Press the botton to be redirected to the website of Elesta distributor in USA